These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 10635408)

  • 1. Induction and adjuvant chemotherapy for head and neck cancer: future perspectives.
    Forastiere AA
    Acta Otorhinolaryngol Belg; 1999; 53(3):277-80. PubMed ID: 10635408
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of chemotherapy in the curative treatment of head and neck cancer.
    Pfister DG; Shaha AR; Harrison LB
    Surg Oncol Clin N Am; 1997 Oct; 6(4):749-68. PubMed ID: 9309092
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intensity-modulated radiation treatment for head-and-neck squamous cell carcinoma--the University of Iowa experience.
    Yao M; Dornfeld KJ; Buatti JM; Skwarchuk M; Tan H; Nguyen T; Wacha J; Bayouth JE; Funk GF; Smith RB; Graham SM; Chang K; Hoffman HT
    Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):410-21. PubMed ID: 16168834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Advances in the treatment of head and neck tumors. I. Chemotherapy].
    Stupp R; Vokes EE
    Strahlenther Onkol; 1995 Jan; 171(1):12-7. PubMed ID: 7839300
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction chemotherapy: to use or not to use? That is the question.
    Brizel DM; Vokes EE
    Semin Radiat Oncol; 2009 Jan; 19(1):11-6. PubMed ID: 19028340
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Defining risk levels in locally advanced head and neck cancers: a comparative analysis of concurrent postoperative radiation plus chemotherapy trials of the EORTC (#22931) and RTOG (# 9501).
    Bernier J; Cooper JS; Pajak TF; van Glabbeke M; Bourhis J; Forastiere A; Ozsahin EM; Jacobs JR; Jassem J; Ang KK; Lefèbvre JL
    Head Neck; 2005 Oct; 27(10):843-50. PubMed ID: 16161069
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Paradigm shift in the treatment of head and neck cancer: the role of neoadjuvant chemotherapy.
    Posner MR
    Oncologist; 2005; 10 Suppl 3():11-9. PubMed ID: 16368867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction chemotherapy in the management of squamous cell carcinoma of the head and neck.
    Roman E; Raez LE; Santos ES
    Expert Rev Anticancer Ther; 2006 Sep; 6(9):1205-15. PubMed ID: 17020455
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Options for preserving the larynx in patients with advanced laryngeal and hypopharyngeal cancer.
    Wolf GT
    Ear Nose Throat J; 2001 Dec; 80(12):897-901. PubMed ID: 11775526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemoradiation after surgery for high-risk head and neck cancer patients: how strong is the evidence?
    Bernier J; Cooper JS
    Oncologist; 2005 Mar; 10(3):215-24. PubMed ID: 15793225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Role of Chemotherapy in head and neck cancer].
    Kohno N; Kitahara S
    Gan To Kagaku Ryoho; 2001 Apr; 28(4):448-53. PubMed ID: 11329777
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Delayed regional metastases, distant metastases, and second primary malignancies in squamous cell carcinomas of the larynx and hypopharynx.
    Spector JG; Sessions DG; Haughey BH; Chao KS; Simpson J; El Mofty S; Perez CA
    Laryngoscope; 2001 Jun; 111(6):1079-87. PubMed ID: 11404625
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Control of nodal metastases in squamous cell head and neck cancer treated by radiation therapy or chemoradiation.
    Vergeer MR; Doornaert P; Leemans CR; Buter J; Slotman BJ; Langendijk JA
    Radiother Oncol; 2006 Apr; 79(1):39-44. PubMed ID: 16632006
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Induction chemotherapy and larynx preservation: is such practice useful?].
    Sarini J; Bocciolini C; Fournier C; Penel N; Kara A; Van JT; Lefebvre JL
    Bull Cancer; 2002 Apr; 89(4):411-7. PubMed ID: 12016041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The effect of the microenvironment of head and neck cancers on tumor progression].
    Lukits J
    Magy Onkol; 2009 Mar; 53(1):51-9. PubMed ID: 19318327
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Altered fractionation and/or adjuvant chemotherapy in definitive irradiation of squamous cell carcinoma of the head and neck.
    Mendenhall WM; Riggs CE; Amdur RJ; Hinerman RW; Villaret DB
    Laryngoscope; 2003 Mar; 113(3):546-51. PubMed ID: 12616212
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence-based radiation oncology in head and neck squamous cell carcinoma.
    Corvò R
    Radiother Oncol; 2007 Oct; 85(1):156-70. PubMed ID: 17482300
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of chemotherapy for advanced oro and hypopharyngeal cancer.
    Kohno N
    Auris Nasus Larynx; 2004 Jun; 31(2):113-8. PubMed ID: 15121218
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Searching for less toxic larynx preservation: a need for common definitions and metrics.
    Forastiere AA; Trotti AM
    J Natl Cancer Inst; 2009 Feb; 101(3):129-31. PubMed ID: 19176460
    [No Abstract]   [Full Text] [Related]  

  • 20. Long-term neck control rates after complete response to chemoradiation in patients with advanced head and neck cancer.
    Rengan R; Pfister DG; Lee NY; Kraus DH; Shah JP; Shaha AR; Ben-Porat LS; Zelefsky MJ
    Am J Clin Oncol; 2008 Oct; 31(5):465-9. PubMed ID: 18838883
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.